Showing results (81-90 of 675) with videos related to

Sort By:
Pageof 68
European Journal of Human Genetics : EJHG|September 12, 2013
Variants at IRX4 as prostate cancer expression quantitative trait lociXing Xu, Wasay M Hussain, Joseph Vijai, et al.
JAMA Network Open|May 20, 2022
Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing GuidelinesTimothy A Yap, Arya Ashok, Jessica Stoll, et al.
Leukemia & Lymphoma|April 15, 2003
BRCA1 and BRCA2 germline mutations in lymphoma patientsOrit Yossepowitch, Narciso Olvera, Jaya M Satagopan, et al.
Data in Brief|December 22, 2021
Assessment of genomic alterations in non-syndromic von Hippel-Lindau: Insight from integrating somatic and germline next generation sequencing genomic dataDanielle K Manning, Priyanka Shivdasani, Diane R Koeller, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 26, 2013
Distress and the parenting dynamic among BRCA1/2 tested mothers and their partnersDarren Mays, Tiffani A DeMarco, George Luta, et al.
American Journal of Surgery|June 14, 2006
The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapyMehra Golshan, Alex Miron, Asa J Nixon, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 25, 2016
The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk WomenYongLi Ji, Tiffany Rounds, Abigail Crocker, et al.
Breast Cancer Research and Treatment|March 1, 2023
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interceptionBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Breast Cancer Research and Treatment|April 5, 2022
Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifenBrittany Bychkovsky, Alison Laws, Fisher Katlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2026
The biology of hypomorphic TP53 variants and implications for clinical managementRenyta Moses, Jacquelyn Powers, Alison S Levine, et al.
Pageof 68